GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Cash Flow from Financing

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Cash Flow from Financing : ¥-701 Mil (TTM As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2024, Zhejiang Huahai Pharmaceutical Co paid ¥0 Mil more to buy back shares than it received from issuing new shares. It received ¥20 Mil from issuing more debt. It paid ¥0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent ¥324 Mil paying cash dividends to shareholders. It spent ¥5 Mil on other financial activities. In all, Zhejiang Huahai Pharmaceutical Co spent ¥309 Mil on financial activities for the three months ended in Sep. 2024.


Zhejiang Huahai Pharmaceutical Co Cash Flow from Financing Historical Data

The historical data trend for Zhejiang Huahai Pharmaceutical Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huahai Pharmaceutical Co Cash Flow from Financing Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -400.33 596.35 1,118.35 609.04 -644.23

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,046.01 -94.72 1,093.03 -1,390.04 -309.21

Zhejiang Huahai Pharmaceutical Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Zhejiang Huahai Pharmaceutical Co's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Zhejiang Huahai Pharmaceutical Co's Cash from Financing for the quarter that ended in Sep. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-701 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Huahai Pharmaceutical Co  (SHSE:600521) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Zhejiang Huahai Pharmaceutical Co's issuance of stock for the three months ended in Sep. 2024 was ¥0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Zhejiang Huahai Pharmaceutical Co's repurchase of stock for the three months ended in Sep. 2024 was ¥0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Zhejiang Huahai Pharmaceutical Co's net issuance of debt for the three months ended in Sep. 2024 was ¥20 Mil. Zhejiang Huahai Pharmaceutical Co received ¥20 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Zhejiang Huahai Pharmaceutical Co's net issuance of preferred for the three months ended in Sep. 2024 was ¥0 Mil. Zhejiang Huahai Pharmaceutical Co paid ¥0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Zhejiang Huahai Pharmaceutical Co's cash flow for dividends for the three months ended in Sep. 2024 was ¥-324 Mil. Zhejiang Huahai Pharmaceutical Co spent ¥324 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Zhejiang Huahai Pharmaceutical Co's other financing for the three months ended in Sep. 2024 was ¥-5 Mil. Zhejiang Huahai Pharmaceutical Co spent ¥5 Mil on other financial activities.


Zhejiang Huahai Pharmaceutical Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Zhejiang Huahai Pharmaceutical Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Huahai Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Xunqiao, Zhejiang Province, Linhai, Linhai, CHN, 317024
Zhejiang Huahai Pharmaceutical Co Ltd is engaged in Research & Development, production and sales of multi-dosage preparations, biological drugs, innovative drugs and specialty APIs.
Executives
Lin Li Hong senior management
Xu Mi senior management
Gang Hui senior management
He Bin senior management
Kong Xiao Fang senior management
Chen Bao Hua Director
Shang Fei senior management
Du Jun Director
Su Yan Director
Chen Dun Yuan senior management
Li Hong Director
Guo Si Jia senior management
Li Min senior management
Xu Bo senior management
Chen Qi Mao senior management

Zhejiang Huahai Pharmaceutical Co Headlines

No Headlines